AI Tokens
Stock Analysis on Net

Align Technology Inc. (NASDAQ:ALGN)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Enterprise Value to EBITDA (EV/EBITDA)

Microsoft Excel

Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)

Align Technology Inc., EBITDA calculation

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net income 361,573 772,020 1,775,888 442,776 400,235
Add: Income tax expense 237,484 240,403 (1,396,939) 112,347 57,723
Earnings before tax (EBT) 599,057 1,012,423 378,949 555,123 457,958
Add: Interest expense — — — — —
Earnings before interest and tax (EBIT) 599,057 1,012,423 378,949 555,123 457,958
Add: Depreciation and amortization 125,793 108,729 93,538 78,990 54,727
Earnings before interest, tax, depreciation and amortization (EBITDA) 724,850 1,121,152 472,487 634,113 512,685

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


The financial performance from 2018 to 2022 is characterized by significant volatility in earnings and a notable divergence between operating results and net income in specific periods. While there was a substantial peak in operational profitability in 2021, the overall trajectory shows fluctuations rather than a linear growth pattern.

EBITDA Trend Analysis
Earnings before interest, tax, depreciation and amortization exhibited an inconsistent growth trajectory. After an initial increase from 512,685 thousand US$ in 2018 to 634,113 thousand US$ in 2019, a contraction occurred in 2020, with values dropping to 472,487 thousand US$. This was followed by a sharp surge in 2021, where EBITDA reached a period peak of 1,121,152 thousand US$, before declining to 724,850 thousand US$ in 2022.
Depreciation and Amortization Growth
A steady upward trend is observed in the difference between EBITDA and EBIT, which represents depreciation and amortization expenses. This gap expanded consistently every year: from 54,727 thousand US$ in 2018 to 125,793 thousand US$ by 2022. This indicates a continuous increase in non-cash charges, likely reflecting ongoing capital expenditures or asset acquisitions over the five-year period.
Operating Profitability and Interest Impact
Earnings before interest and tax (EBIT) and Earnings before tax (EBT) remained identical across all reported years. This parity suggests that interest income and interest expenses had a negligible or neutral net impact on the company's pre-tax earnings during this timeframe.
Net Income Divergence
A significant anomaly is observed in 2020, where net income reached 1,775,888 thousand US$, vastly exceeding the EBT of 378,949 thousand US$. This discrepancy indicates the presence of substantial non-operating gains or one-time tax benefits. Conversely, in 2021 and 2022, net income fell below EBT, reflecting the impact of taxes and other expenses on the final bottom line.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Enterprise Value to EBITDA Ratio, Current

Align Technology Inc., current EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in thousands)
Enterprise value (EV) 14,122,171
Earnings before interest, tax, depreciation and amortization (EBITDA) 724,850
Valuation Ratio
EV/EBITDA 19.48
Benchmarks
EV/EBITDA, Competitors1
Abbott Laboratories 16.66
Elevance Health Inc. 9.26
Intuitive Surgical Inc. 39.26
Medtronic PLC 15.64
UnitedHealth Group Inc. 17.82
EV/EBITDA, Sector
Health Care Equipment & Services 15.02
EV/EBITDA, Industry
Health Care 20.66

Based on: 10-K (reporting date: 2022-12-31).

1 Click competitor name to see calculations.

If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.


Enterprise Value to EBITDA Ratio, Historical

Align Technology Inc., historical EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Enterprise value (EV)1 22,338,984 39,216,076 43,916,116 16,327,126 19,979,482
Earnings before interest, tax, depreciation and amortization (EBITDA)2 724,850 1,121,152 472,487 634,113 512,685
Valuation Ratio
EV/EBITDA3 30.82 34.98 92.95 25.75 38.97
Benchmarks
EV/EBITDA, Competitors4
Abbott Laboratories 15.85 17.42 — — —
Elevance Health Inc. 10.26 10.05 — — —
Intuitive Surgical Inc. 40.96 44.10 — — —
Medtronic PLC 14.99 24.41 — — —
UnitedHealth Group Inc. 15.11 17.39 — — —
EV/EBITDA, Sector
Health Care Equipment & Services 15.26 18.05 — — —
EV/EBITDA, Industry
Health Care 14.00 14.33 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 See details »

2 See details »

3 2022 Calculation
EV/EBITDA = EV ÷ EBITDA
= 22,338,984 ÷ 724,850 = 30.82

4 Click competitor name to see calculations.


The Enterprise Value to EBITDA (EV/EBITDA) ratio exhibited significant volatility between 2018 and 2022, characterized by an extreme peak in 2020 followed by a period of correction and stabilization. The ratio shifted from 38.97 in 2018 to a high of 92.95 in 2020, before returning to a range of approximately 30x to 35x in the final two years of the period.

Enterprise Value (EV) Fluctuations
A substantial increase in Enterprise Value was observed starting in 2020, where the value surged to US$ 43.9 billion from a 2019 low of US$ 16.3 billion. This peak was followed by a gradual decline through 2021 and a more pronounced contraction in 2022, ending the period at US$ 22.3 billion.
EBITDA Performance Trends
Operational earnings demonstrated an inconsistent growth trajectory. After an initial increase in 2019, EBITDA declined to US$ 472.5 million in 2020. A significant recovery occurred in 2021, with EBITDA reaching a peak of US$ 1.12 billion, before receding to US$ 724.9 million in 2022.
Analysis of the EV/EBITDA Ratio
The dramatic spike in the EV/EBITDA ratio to 92.95 in 2020 was driven by the divergence of a sharply increasing market valuation and a simultaneous dip in operational earnings. The subsequent normalization to 34.98 in 2021 and 30.82 in 2022 indicates a realignment of the enterprise valuation with the company's actual earnings capacity.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?